← Leaderboards
Walter J Curran
Thomas Jefferson University
$890,256
Attributed
$890,256
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$46,226,987 · 6
By mechanism
U10$40,750,065 · 4
P01$5,476,922 · 2
Top collaborators
No co-investigators on record.
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Walter John Curran$19,392,586
- Ya Wang$3,768,156
- Agnieszka Witkiewicz$7,548,076
- Scott A. Waldman$27,830,994
- Carlo M Croce$37,904,390
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman Therapy EvaluationHuman SubjectNeoplasm /Cancer Radiation TherapyNeoplasm /Cancer SurgeryColorectal NeoplasmsCombination Cancer TherapyAntineoplasticsNeoplasm /Cancer ChemotherapyClinical TrialsCombination ChemotherapyCooperative StudyReproductive System NeoplasmHead /Neck NeoplasmBrain NeoplasmsNeoplasm /Cancer GeneticsUrinary Tract NeoplasmsNeoplasm /CancerLung NeoplasmsGastrointestinal NeoplasmsAdenocarcinomaCamptothecinClinical Trial Phase IFluorouracil
Grant awards (25)
RADIATION THERAPY ONCOLOGY GROUP$8,232,670
U10 · FY2003 · CA
RELEVANCE OF GENOMIC ALTERATIONS IN COLORECTAL CANCER$1,160,271
P01 · FY2003 · CA
COMMUNITY CLINICAL ONCOLOGY PROGRAM RESEARCH BASE$914,646
U10 · FY2003 · CA
RADIATION THERAPY ONCOLOGY GROUP$749,739
U10 · FY2003 · CA
RELEVANCE OF GENOMIC ALTERATIONS IN COLORECTAL CANCER$17,422
P01 · FY2003 · CA
RTOG Foreign Accrual$0
U10 · FY2003 · CA
Foreign Accrual - RTOG$0
U10 · FY2003 · CA
RADIATION THERAPY ONCOLOGY GROUP$9,394,973
U10 · FY2002 · CA
RELEVANCE OF GENOMIC ALTERATIONS IN COLORECTAL CANCER$1,129,628
P01 · FY2002 · CA
COMMUNITY CLINICAL ONCOLOGY PROGRAM RESEARCH BASE$565,667
U10 · FY2002 · CA
INNOVATIVE APPROACHES TO PATIENTS WITH ADENOCARCINOMA$296,752
P01 · FY2002 · CA
INNOVATIVE APPROACHES TO PATIENTS WITH ADENOCARCINOMA$296,752
P01 · FY2002 · CA
RADIATION THERAPY ONCOLOGY GROUP$200,000
U10 · FY2002 · CA
RADIATION THERAPY ONCOLOGY GROUP$135,118
U10 · FY2002 · CA
RELEVANCE OF GENOMIC ALTERATIONS IN COLORECTAL CANCER$47,100
P01 · FY2002 · CA
RADIATION THERAPY ONCOLOGY GROUP$8,726,169
U10 · FY2001 · CA
COMMUNITY CLINICAL ONCOLOGY PROGRAM RESEARCH BASE$1,418,941
U10 · FY2001 · CA
RELEVANCE OF GENOMIC ALTERATIONS IN COLORECTAL CANCER$1,094,222
P01 · FY2001 · CA
INNOVATIVE APPROACHES TO PATIENTS WITH ADENOCARCINOMA$296,752
P01 · FY2001 · CA
RELEVANCE OF GENOMIC ALTERATIONS IN COLORECTAL CANCER$47,100
P01 · FY2001 · CA
INNOVATIVE APPROACHES TO PATIENTS WITH ADENOCARCINOMA$0
P01 · FY2001 · CA
RADIATION THERAPY ONCOLOGY GROUP$9,191,105
U10 · FY2000 · CA
COMMUNITY CLINICAL ONCOLOGY PROGRAM RESEARCH BASE$1,221,037
U10 · FY2000 · CA
RELEVANCE OF GENOMIC ALTERATIONS IN COLORECTAL CANCER$1,090,923
P01 · FY2000 · CA
INNOVATIVE APPROACHES TO PATIENTS WITH ADENOCARCINOMA$0
P01 · FY2000 · CA